Sanofi Multiple Sclerosis Drug Gets EU Approval
Sanofi said it received European Union approval for Cenrifki, a new multiple sclerosis medicine, after U.S. regulators rejected it.
Connecting Global Economies
Flash News
Eight potential Senators trade targets: What’s next with Brady Tkachuk gone?
Opinion | Anxious West seeks to rewrite global trade rules to counter China
The Club’s top 10 things to watch in the stock market Tuesday
Taylor Swift Attends Travis Kelce’s Tight End University Party
England vs Ghana live updates: World Cup 2026 game latest news and buildup
Sanofi Multiple Sclerosis Drug Gets EU Approval
Former Scottish National Party chief Peter Murrell jailed for embezzling party funds
AI memory startup focused on cutting token costs raises $98 million
TikTok-Viral Prime Day Makeup Under $25: e.l.f., Tarte, Clinique, L’Oreal
Giannis Antetokounmpo traded to Heat on eve of NBA Draft: Live updates, reaction and more
Tuesday, June 23, 2026